Sexuality after breast cancer - A study of the sexual health of patients and their partners

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00032420

Enrollment

126

Registered

2023-09-29

Start date

2023-04-26

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sexual Health after Breast Cancer

Interventions

Group 1: Arm 1: Patients who underwent surgery for primary breast cancer at Mainz University Medical Center (BET or mastectomy) from January 2017 to June 2022 will be surveyed once with a questionnair

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Arm 1: female sex, history of breast cancer, primary therapy (surgery, radiotherapy, chemotherapy) completed within 5 years prior to treatment initiation, current partnership, age between 18 and 80 years. Arm 2: all sexes, current partnership with patient from Arm 1, no breast cancer in medical history, age over 18 years

Exclusion criteria

Exclusion criteria: Arm 1: male sex, ongoing primary therapy (surgery, radiotherapy, chemotherapy), no current partnership, age less than 18 or greater than 80 years Arm 2: medical history of breast cancer, age less than 18 years.

Design outcomes

Primary

Measure	Time frame
The aim of the present work is to investigate the sexual health of breast cancer patients and their partners. The following endpoints will be investigated: 1. sexual satisfaction (EORTC Sexual Health Questionnaire (SHQ-22)) 2. sexual functioning (EORTC Sexual Health Questionnaire (SHQ-22)) 3. erectile functioning in the collective of male partners (Erectile Function Domaine des IIEF) 4. subjectively perceived change in satisfaction with partner sexuality before and since diagnosis? (Question (2) of the questionnaire see above). 5. need for information regarding possible changes in sexuality in the context of breast cancer and its therapy? (Questionnaire on sexual health care (5) see above). The parameters will be checked once in the period of up to 5 years after the end of the breast cancer therapy (surgery, chemotherapy, radiation), anti-hormone therapies and/or targeted therapies do not have to be finished at the time of study participation.	—

Measure

Time frame

The aim of the present work is to investigate the sexual health of breast cancer patients and their partners. The following endpoints will be investigated: 1. sexual satisfaction (EORTC Sexual Health Questionnaire (SHQ-22)) 2. sexual functioning (EORTC Sexual Health Questionnaire (SHQ-22)) 3. erectile functioning in the collective of male partners (Erectile Function Domaine des IIEF) 4. subjectively perceived change in satisfaction with partner sexuality before and since diagnosis? (Question (2) of the questionnaire see above). 5. need for information regarding possible changes in sexuality in the context of breast cancer and its therapy? (Questionnaire on sexual health care (5) see above). The parameters will be checked once in the period of up to 5 years after the end of the breast cancer therapy (surgery, chemotherapy, radiation), anti-hormone therapies and/or targeted therapies do not have to be finished at the time of study participation.

—

Secondary

Measure	Time frame
Depression symptoms (PHQ-9) Impact of the COVID-19 pandemic on partnership and sexuality (single question assessing the subjectively perceived impact of the pandemic on sexuality and partnership). Subgroup analyses	—

Countries

Germany

Contacts

Public ContactAnnette Hasenburg

Klinik und Poliklinik für Geburtshilfe und Frauengesundheit der Universitätsmedizin Mainz

Annette.Hasenburg@unimedizin-mainz.de+49 6131 17-7311

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026